Abstract
The current outbreak of novel coronavirus disease 2019 (COVID-19) is already causing a serious disease burden worldwide, this paper analyzed data of a delta variant Covid-19 outbreak in Hunan, China, and proposed an optimal dose-wise dynamical vaccinating process based on local contact pattern and vaccine coverage that minimize the accumulative cases in a certain future time interval. The optimized result requires an immediate vaccination to that none vaccinated at age group 30 to 39, which is coherent to the prevailing strategies. The dose-wise optimal vaccinating process can be directive for countries or regions where vaccines are not abundant. We recommend that vaccination should be further intensified to increase the coverage of booster shots, thus effectively reducing the spread of COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Bill & Melinda Gates Foundation (INV-005834), and the Impact on prevention and control COVID-19 of vaccination intention and effectiveness: a modelling study(2021YFC2301604).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Emails:
Xiaohao Guo: guo3.1415926536{at}qq.com
Ziyan Liu:1715773383{at}qq.com
Shiting Yang: yst3393{at}163.com
Zeyu Zhao: 381597586{at}qq.com
Yichao Guo: 564931539{at}qq.com
Guzainuer Abudurusuli: 748693650{at}qq.com
Jia Rui: 2931438521{at}qq.com
Yao Wang: 812304436{at}qq.com
Shanlu Zhao: 1654919009{at}qq.com
Ge Zeng: 244870450{at}qq.com
Shixiong Hu: 379788967{at}qq.com
Kaiwei Luo: 87616498{at}qq.com
Tianmu Chen: 13698665{at}qq.com
Data Availability
All data produced in the present study are available upon reasonable request to the authors